Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients Hugo J.A. AdamsThomas C. Kwee Review Article Open access 07 December 2019 Pages: 1 - 5
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion Sophie ParkCharikleia KelaidiUwe Platzbecker Review Article Open access 25 October 2019 Pages: 7 - 19
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion Sophie ParkCharikleia KelaidiUwe Platzbecker Correction Open access 02 December 2019 Pages: 21 - 21
A novel SNP rs11759328 on Rho GTPase-activating protein 18 gene is associated with the expression of Hb F in hemoglobin E-related disorders Wittaya JomouiWanicha TepakhanSupan Fucharoen Original Article 27 November 2019 Pages: 23 - 29
Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia Rasha Abd El-Rahman El-GamalIbrahim Youssef Abdel-MessihShaimaa Abdelmalik Pessar Original Article 13 December 2019 Pages: 31 - 39
The increased neopterin content in turkish pediatric patients with sickle cell anemia Suna SabuncuoğluYeşim ÖztaşGözde Girgin Original Article 23 November 2019 Pages: 41 - 47
Evaluation of thrombotic events in patients with immune thrombocytopenia Shoko ItoShin-ichiro FujiwaraYoshinobu Kanda Original Article 18 December 2019 Pages: 49 - 55
Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia Rahul KaundalPrateek BhatiaDeepesh P. Lad Original Article 06 December 2019 Pages: 57 - 63
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice Massimo BrecciaClaudia BaratèFrancesca Palandri Original Article Open access 12 December 2019 Pages: 65 - 72
The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia Meng-Ge GaoGuo-Rui RuanXiao-Su Zhao Original Article 25 November 2019 Pages: 73 - 82
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas Seo-Yeon AhnSeung-Yeon JungDeok-Hwan Yang Original Article 06 December 2019 Pages: 83 - 91
Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases Xiang-Gui YuanYu-Rong HuangXiao-Ying Zhao Original Article 22 November 2019 Pages: 93 - 104
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial Andrea KühnlClare PeckittDavid Cunningham Original Article 27 November 2019 Pages: 105 - 112
Clinical impact of the CONUT score in patients with multiple myeloma Sho OkamotoHiroshi UreshinoShinya Kimura Original Article 25 November 2019 Pages: 113 - 119
The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma Ang LiQian WuGary H. Lyman Original Article 26 November 2019 Pages: 121 - 126
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma Rosa FontiSara PellegrinoLeonardo Pace Original Article 27 November 2019 Pages: 127 - 135
Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma Reiko IsaNobuhiko UoshimaKyoto Clinical Hematology Study Group investigators Original Article 25 November 2019 Pages: 137 - 145
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia Tatsuya KonishiNoriko DokiKazuteru Ohashi Original Article 30 November 2019 Pages: 147 - 155
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine) Albert EsquirolSergi QuerolJorge Sierra Original Article 17 December 2019 Pages: 157 - 165
Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies Liping DouCheng HouDaihong Liu Original Article Open access 11 December 2019 Pages: 167 - 179
Daratumumab-associated hemophagocytic lymphohistiocytosis Ashley WoodsMelanie WootenEdmund Waller Letter to the Editor 17 December 2019 Pages: 181 - 182
Atypical mycobacteria diagnosed by bone marrow biopsy in an HIV-positive patient Magda ZanelliMaurizio ZizzoStefano Ascani Letter to the Editor 06 December 2019 Pages: 183 - 184
MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia Jiewen SunWenjuan YuXiang Zhang Letter to the Editor 28 November 2019 Pages: 185 - 188
Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes Shinji OguraShoichiro YoneiTomonori Nakazato Letter to the Editor 26 November 2019 Pages: 189 - 191
Bilateral vision loss in Waldenstrom’s macroglobulinemia Vasiliki VasileiouMaria KotoulaEleni Papageorgiou Letter to the Editor 07 December 2019 Pages: 193 - 194
Systemic mastocytosis associated with acute myeloid leukemia Frederico Lisboa NogueiraNaira Neves Neto MartinsEvandro Maranhão Fagundes Letter to the Editor 25 November 2019 Pages: 195 - 196
Congenital dyserythropoietic anemia type I mimicking myelodysplasia syndrome with a novel CDAN1 mutation Xueyan LvShanwu DongRunming Jin Letter to the Editor 23 November 2019 Pages: 197 - 199
A case of polycyclic Sweet’s syndrome arising from azacitidine injection sites in myelodysplasia William A. BerryRobert Kelly Letter to the Editor 09 December 2019 Pages: 201 - 202
Magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in neurolymphomatosis: an uncommon presentation of diffuse large B cell lymphoma Marta D. SwitlykAnnette T. SkeieBjørn Østenstad Letter to the Editor 25 November 2019 Pages: 203 - 205
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT Livio PaganoAlessio Maria Edoardo MaraglinoValerio De Stefano Letter to the Editor 12 December 2019 Pages: 207 - 209
Iron deficiency: an independent prognostic marker in heart failure Kamal Kant SahuAjay Kumar MishraAhmad Daniyal Siddiqui Letter to the Editor 09 December 2019 Pages: 211 - 212
Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores Hyewon LeeYu Ri KimJin Seok Kim Correction 16 December 2019 Pages: 213 - 213